Transgenic animals with inducible, targeted gene expression in brain

被引:141
作者
Chen, JS
Kelz, MB
Zeng, GQ
Sakai, N
Steffen, C
Shockett, PE
Picciotto, MR
Duman, RS
Nestler, EJ
机构
[1] Yale Univ, Sch Med, Dept Psychiat, Lab Mol Psychiat, New Haven, CT 06508 USA
[2] Yale Univ, Sch Med, Dept Psychiat, Ctr Genes & Behav, New Haven, CT 06508 USA
[3] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06508 USA
[4] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA
关键词
D O I
10.1124/mol.54.3.495
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several inducible gene expression systems have been developed in vitro in recent years to overcome limitations with traditional transgenic mice. One of these, the tetracycline-regulated system, has been used successfully in vivo. Nevertheless, concerns remain about the ability of this system to direct high levels of transgene expression in vivo and to enable such expression to be turned on and off effectively. We report here the generation, using a modified tetracycline-regulated system under the control of the neuron-specific enolase promoter, of several lines of mice that direct transgene expression to specific brain regions, including the striatum, cerebellum CA1 region of the hippocampus, or deep layers of cerebral neocortex. Transgene expression in these mice can be turned off completely with low doses of doxycycline (a tetracycline derivative) and driven to very high levels in the absence of doxycycline. We demonstrate this tissue-specific, inducible expression for three transgenes: those that encode luciferase (a reporter protein) or Delta FosB or the cAMP-response element binding protein (CREB) (two transcription factors). The various lines of transgenic mice demonstrate an inducible system that generates high levels of transgene expression in specific brain regions and represent novel and powerful tools with which to study the functioning of these (or potentially any other) genes in the brain.
引用
收藏
页码:495 / 503
页数:9
相关论文
共 37 条
  • [1] Chen J. S., 1997, Society for Neuroscience Abstracts, V23, P410
  • [2] Chen JS, 1997, J NEUROSCI, V17, P4933
  • [3] Duman R. S., 1997, Society for Neuroscience Abstracts, V23, P410
  • [4] Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597
  • [5] BCL-2 TRANSGENE EXPRESSION CAN PROTECT NEURONS AGAINST DEVELOPMENTAL AND INDUCED CELL-DEATH
    FARLIE, PG
    DRINGEN, R
    REES, SM
    KANNOURAKIS, G
    BERNARD, O
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (10) : 4397 - 4401
  • [6] TRANSGENIC MICE EXPRESSING BETA-GALACTOSIDASE IN MATURE NEURONS UNDER NEURON-SPECIFIC ENOLASE PROMOTER CONTROL
    FORSSPETTER, S
    DANIELSON, PE
    CATSICAS, S
    BATTENBERG, E
    PRICE, J
    NERENBERG, M
    SUTCLIFFE, JG
    [J]. NEURON, 1990, 5 (02) : 187 - 197
  • [7] Freundlieb S, 1997, METHOD ENZYMOL, V283, P159
  • [8] Inducible gene expression in the nervous system of transgenic mice
    Gingrich, JR
    Roder, J
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 1998, 21 : 377 - 405
  • [9] TIGHT CONTROL OF GENE-EXPRESSION IN MAMMALIAN-CELLS BY TETRACYCLINE-RESPONSIVE PROMOTERS
    GOSSEN, M
    BUJARD, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) : 5547 - 5551
  • [10] TRANSCRIPTIONAL ACTIVATION BY TETRACYCLINES IN MAMMALIAN-CELLS
    GOSSEN, M
    FREUNDLIEB, S
    BENDER, G
    MULLER, G
    HILLEN, W
    BUJARD, H
    [J]. SCIENCE, 1995, 268 (5218) : 1766 - 1769